Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4533 (MIR4533) is a member of the microRNA family, a class of small non-coding RNAs involved in the regulation of gene expression at the post-transcriptional level. miRNAs typically function by binding to complementary sequences in the 3' untranslated regions (UTRs) of messenger RNAs, leading to mRNA degradation or translational repression[1][4][5]. The biological and disease roles of most miRNAs are context-dependent and require experimental validation. As of now, there is no evidence that MIR4533 functions as a canonical therapeutic protein target (e.g., receptor, enzyme, transporter), nor have drugs or disease associations been established for this particular miRNA. MicroRNAs (miRNAs) are short (~22 nucleotides) noncoding RNAs, prevalent in animals and plants, that regulate gene expression primarily by binding to target mRNAs, resulting in translational inhibition or mRNA degradation[1][5]. miRNAs as a class broadly influence cellular activities such as cell proliferation, differentiation, apoptosis, and more, but specific functions for many individual miRNAs (including MIR4533) remain uncharacterized in the literature[2][4][5]. There is currently no record in scientific literature or clinical databases indicating that MIR4533 acts as a disease biomarker, drug target, or has associated interacting drugs. The name and identifiers presented for this target (microRNA 4533, MIR4533, hsa-mir-4533) follow the standardized conventions for naming human miRNAs. MIR4533 is not a canonical druggable target such as a receptor, enzyme, or transporter. Instead, it is a gene regulatory RNA. Individual miRNAs sometimes serve as disease biomarkers or therapeutic targets in research or experimental therapy, but no data supports this for MIR4533 specifically[7]. The "is_incorrect" field is set to true due to the absence of recognized biochemical or therapeutic target status and lack of detailed characterization for MIR4533. MIR4533 is a human microRNA gene, not a conventional therapeutic target such as a receptor or enzyme. Little is known about its specific biological or disease relevance, and it is not an established biomarker or drug target based on current knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4533 (MIR4533).